Skip to content

13F-HR filed by Essex Woodlands Management, Inc.

Essex Woodlands Management, Inc. filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-15, with 10 holding rows worth $438,256,000.

Accession
0001398344-17-006361
Filed
2017-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2017

A holdings report, 10 entries on the cover page, a total value of $438,256,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $438,258,000 with VALUE read as thousands by filing date, 13F file number 028-14839. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ABIOMED INC003654100COM1,450,000$181,540,000thousands by filing date
REVANCE THERAPEUTICS INC761330109COM4,592,047$95,515,000thousands by filing date
AXOGEN INC05463X106COM4,861,111$50,799,000thousands by filing date
ENTELLUS MED INC29363K105COM3,231,656$44,597,000thousands by filing date
CORIUM INTL INC21887L107COM9,353,304$39,097,000thousands by filing date
ENDOLOGIX INC29266S106COM1,257,468$14,484,000thousands by filing date
MEDICINOVA INC58468P206COM NEW1,170,370$7,011,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW30,996$3,281,000thousands by filing date
ACURA PHARMACEUTICALS INC COM00509L802COM1,956,397$1,177,000thousands by filing date
CATALYST14888D109COM78,622$757,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001398344-17-006361this filing2017-05-15acceptance time not in the bulk data set